Cargando…
Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review
IMPORTANCE: Most frequent worldwide cause of permanent blindness is glaucoma. Early in the course of the disease, glaucoma affects many patients without any symptoms. In order to examine for indications of glaucoma and to ascertain whether systemic illnesses or drugs can raise a patient's risk...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905872/ https://www.ncbi.nlm.nih.gov/pubmed/36793264 http://dx.doi.org/10.5005/jp-journals-10078-1388 |
_version_ | 1784883895673552896 |
---|---|
author | Joshi, Poonam Dangwal, Aayush Guleria, Itika Kothari, Sunil Singh, Pooja Kalra, Jyoti M Jakhmola, Vikas |
author_facet | Joshi, Poonam Dangwal, Aayush Guleria, Itika Kothari, Sunil Singh, Pooja Kalra, Jyoti M Jakhmola, Vikas |
author_sort | Joshi, Poonam |
collection | PubMed |
description | IMPORTANCE: Most frequent worldwide cause of permanent blindness is glaucoma. Early in the course of the disease, glaucoma affects many patients without any symptoms. In order to examine for indications of glaucoma and to ascertain whether systemic illnesses or drugs can raise a patient's risk of developing glaucoma, primary care practitioners should be aware of which patients to send to an eye care specialist. A review of the pathogenesis, risk factors, screening, disease monitoring, and treatment options for open-angle and narrow-angle glaucoma are included. OBSERVATIONS: The optic nerve and retinal nerve fiber layer (rNFL) are damaged in glaucoma, a chronic, progressive optic neuropathy that can result in a permanent loss of peripheral or central vision. The only risk factor that is known to be controllable is intraocular pressure (IOP). A family history of glaucoma, older age, and non-white race are additional significant risk factors. Numerous systemic diseases and drugs, such as corticosteroids, anticholinergics, certain antidepressants, and topiramate, can put people at risk of developing glaucoma. Open-angle and angle-closure glaucoma are the two main types of disease. Measurement of IOP, perimetry, and optical coherence tomography are diagnostic procedures to evaluate glaucoma and track the course of the condition. In order to treat glaucoma, IOP must be decreased. This is possible with a variety of glaucoma medication classes, laser surgery, and incisional surgery. VERDICTS AND RELEVANCE: By identifying systemic illnesses and drugs that raise a patient's chance of developing glaucoma and referring high-risk individuals for a thorough ophthalmologic examination, vision loss from glaucoma can be reduced. Clinicians should make sure that patients continue taking their glaucoma drugs as prescribed and should keep an eye out for any negative side effects from any medical or surgical procedures used to treat glaucoma. HOW TO CITE THIS ARTICLE: Joshi P, Dangwal A, Guleria I, et al. Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, categorizing Glaucoma's Stages: A Review. J Curr Glaucoma Pract 2022;16(3):170-178. |
format | Online Article Text |
id | pubmed-9905872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-99058722023-02-14 Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review Joshi, Poonam Dangwal, Aayush Guleria, Itika Kothari, Sunil Singh, Pooja Kalra, Jyoti M Jakhmola, Vikas J Curr Glaucoma Pract Review Article IMPORTANCE: Most frequent worldwide cause of permanent blindness is glaucoma. Early in the course of the disease, glaucoma affects many patients without any symptoms. In order to examine for indications of glaucoma and to ascertain whether systemic illnesses or drugs can raise a patient's risk of developing glaucoma, primary care practitioners should be aware of which patients to send to an eye care specialist. A review of the pathogenesis, risk factors, screening, disease monitoring, and treatment options for open-angle and narrow-angle glaucoma are included. OBSERVATIONS: The optic nerve and retinal nerve fiber layer (rNFL) are damaged in glaucoma, a chronic, progressive optic neuropathy that can result in a permanent loss of peripheral or central vision. The only risk factor that is known to be controllable is intraocular pressure (IOP). A family history of glaucoma, older age, and non-white race are additional significant risk factors. Numerous systemic diseases and drugs, such as corticosteroids, anticholinergics, certain antidepressants, and topiramate, can put people at risk of developing glaucoma. Open-angle and angle-closure glaucoma are the two main types of disease. Measurement of IOP, perimetry, and optical coherence tomography are diagnostic procedures to evaluate glaucoma and track the course of the condition. In order to treat glaucoma, IOP must be decreased. This is possible with a variety of glaucoma medication classes, laser surgery, and incisional surgery. VERDICTS AND RELEVANCE: By identifying systemic illnesses and drugs that raise a patient's chance of developing glaucoma and referring high-risk individuals for a thorough ophthalmologic examination, vision loss from glaucoma can be reduced. Clinicians should make sure that patients continue taking their glaucoma drugs as prescribed and should keep an eye out for any negative side effects from any medical or surgical procedures used to treat glaucoma. HOW TO CITE THIS ARTICLE: Joshi P, Dangwal A, Guleria I, et al. Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, categorizing Glaucoma's Stages: A Review. J Curr Glaucoma Pract 2022;16(3):170-178. Jaypee Brothers Medical Publishers 2022 /pmc/articles/PMC9905872/ /pubmed/36793264 http://dx.doi.org/10.5005/jp-journals-10078-1388 Text en Copyright © 2022; The Author(s). https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2022 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Article Joshi, Poonam Dangwal, Aayush Guleria, Itika Kothari, Sunil Singh, Pooja Kalra, Jyoti M Jakhmola, Vikas Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review |
title | Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review |
title_full | Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review |
title_fullStr | Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review |
title_full_unstemmed | Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review |
title_short | Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review |
title_sort | glaucoma in adults-diagnosis, management, and prediagnosis to end-stage, categorizing glaucoma's stages: a review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905872/ https://www.ncbi.nlm.nih.gov/pubmed/36793264 http://dx.doi.org/10.5005/jp-journals-10078-1388 |
work_keys_str_mv | AT joshipoonam glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview AT dangwalaayush glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview AT guleriaitika glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview AT kotharisunil glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview AT singhpooja glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview AT kalrajyotim glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview AT jakhmolavikas glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview |